Physician profile
Boyd R Wickizer
NPI 1750330353
$1,770.77
in general payments reported to CMS, 2019-2025
17 companies · $520 in 2025
The $520 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $255 · 2021: $178 · 2022: $268 · 2023: $294 · 2024: $91.60 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $600.86 | 2019-2025 | Affinity, Novachor, Puraply |
| Abbvie INC. | $306.31 | 2021-2025 | Dalvance |
| Next Science LLC | $196.17 | 2023 | Xperience, Blastx, Surgx |
| Smith+Nephew, INC. | $181.48 | 2020-2024 | Grafix, Oasis, Renasys Go V2 Home |
| Allergan, INC. | $90.66 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $70.58 | 2019-2023 | Nuzyra |
| Medela LLC | $49.68 | 2020-2021 | |
| Molnlycke Health Care US, LLC | $46.76 | 2025 | Exufiber, Mepilex Border Flex, Mepilex Transfer Ag |
| Janssen Pharmaceuticals, INC | $46.16 | 2020 | |
| Trice Medical, INC. | $40.19 | 2022 | |
| Kerecis Limited | $32.36 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ovik Health, LLC | $32.29 | 2022 | |
| Reddress USA, INC. | $19.36 | 2025 | Actigraft |
| Kci USA, INC. | $16.42 | 2020 | |
| Misonix INC | $14.70 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14.58 | 2023 | |
| Cashflow Solutions, LLC | $12.21 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Wickizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.